Iradimed (IRMD) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)
Iradimed (IRMD) Net Income towards Common Stockholders Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 12.92% |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn | -9.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.63% |
| Mar 31, 2026 | 24.13% |
| Dec 31, 2025 | 43.12% |
| Sep 30, 2025 | 10.44% |
| Jun 30, 2025 | 17.81% |
| Mar 31, 2025 | 13.31% |
| Dec 31, 2024 | 42.69% |
| Sep 30, 2024 | -0.35% |
| Jun 30, 2024 | 17.26% |
| Mar 31, 2024 | 21.45% |
| Dec 31, 2023 | -16.59% |
| Sep 30, 2023 | 47.86% |
| Jun 30, 2023 | 28.97% |
| Mar 31, 2023 | 36.97% |
| Dec 31, 2022 | -14.80% |
| Sep 30, 2022 | 33.03% |
| Jun 30, 2022 | 120.53% |
| Mar 31, 2022 | 79.31% |
| Dec 31, 2021 | 327.39% |
| Sep 30, 2021 | 139.73% |